Comparative epidemiology of Clostridium difficile infection: England and the USA

International Journal for Quality in Health Care

Volumn 29, Issue 6, 2017, Pages 785-791

  King, Alice ^a   Mullish, Benjamin H ^a   Williams, Horace R T ^a   Aylin, Paul ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Clostridium difficile; Comorbidity; Gastrointestinal microbiome; Incidence; Infection control

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; COMORBIDITY; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; DEMENTIA; ENGLAND; FEMALE; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEX FACTOR; UNITED STATES; ADOLESCENT; CHILD; CLOSTRIDIUM INFECTION; INCIDENCE; INFANT; MIDDLE AGED; PEPTOCLOSTRIDIUM DIFFICILE; PRESCHOOL CHILD; STATISTICS AND NUMERICAL DATA; VERY ELDERLY;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; COMORBIDITY; CROSS-SECTIONAL STUDIES; ENGLAND; FEMALE; HUMANS; INCIDENCE; INFANT; INPATIENTS; MALE; MIDDLE AGED; UNITED STATES;

EID: 85040607210     PISSN: 13534505     EISSN: 14643677     Source Type: Journal    
DOI: 10.1093/intqhc/mzx120     Document Type: Article

References (39)

1. Lessa FC, Mu Y, Bamberg WM et al. Burden of Clostridium difficile infection in the United States. N Engl J Med 2015;372:825-34
2. Leffler DA, Lamont JT. Clostridium difficile infection. N Engl J Med 2015;372:1539-48
3. Steiner C, Barrett M et al. HCUP Projections: Clostridium Difficile Hospitalizations 2003-2014. HCUP Projections Report # 2014-03. U.S. Agency for Healthcare Research and Quality. 2014. http://www.hcup-us. ahrq.gov/reports/projections/2014-03.pdf. [Accessed: 1st November 2015]
4. He M, Miyajima F, Roberts P et al. Emergence and global spread of epidemic healthcare-associated Clostridium difficile. Nat Genet 2013;45: 109-13
5. Mullish BH, Marchesi JR, Thursz MR et al. Microbiome manipulation with faecal microbiome transplantation as a therapeutic strategy in Clostridium difficile infection. QJM 2015;108:355-9
6. Cammarota G, Masucci L, Ianiro G et al. Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection. Aliment Pharmacol Ther 2015;41:835-43
7. van Nood E, Vrieze A, Nieuwdorp M et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med 2013;368:407-15
8. NICE. Faecal microbiota transplant for recurrent Clostridium difficile infection. 2014. https://www.nice.org.uk/guidance/ipg485. [Accessed: 1st November 2015]
9. Department of Health. Updated guidance on the diagnosis and reporting of clostridium difficile. 2012 https://www.gov.uk/government/publications/updated-guidance-on-the-diagnosis-and-reporting-ofclostridium-difficile [Accessed: 1st November 2015]
10. Surawicz CM, Brandt LJ, Binion DG et al. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol 2013;108:478-98
11. MacConnachie AA, Fox R, Kennedy DR et al. Faecal transplant for recurrent Clostridium difficile-associated diarrhoea: a UK case series. QJM 2009;102:781-4
12. Satokari R, Mattila E, Kainulainen V et al. Simple faecal preparation and efficacy of frozen inoculum in faecal microbiota transplantation for recurrent Clostridium difficile infection-an observational cohort study. Aliment Pharmacol Ther 2015;41:46-53
13. Hamilton MJ, Weingarden AR, Sadowsky MJ et al. Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection. Am J Gastroenterol 2012;107:761-7
14. Rubin TA, Gessert CE, Aas J et al. Fecal microbiome transplantation for recurrent Clostridium difficile infection: report on a case series. Anaerobe 2013;19:22-6
15. Youngster I, Russell GH, Pindar C et al. Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficile infection. JAMA 2014;312:1772-8
16. Barrett M, Lopez-Gonzalez L, Coffey R et al. Population Denominator Data for use with the HCUP Databases (Updated with 2012 Population data). HCUP Methods Series Report # 2013-01 ONLINE. March 8, 2013 U.S. Agency for Healthcare Research and Quality. Available: http://www.hcup-us.ahrq.gov/reports/methods/methods.jsp
17. Office for National Statistics, The National Archives. Available: https://www.ons.gov.uk/peoplepopulationandcommunity/populationandmigration/populationestimates/datasets/populationestimatesforukenglandandwalesscot landandnorthernireland. Contains public sector information licensed under the Open Government Licence v3.0. Available: http://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/
18. Elixhauser A, Steiner C, Harris DR et al. Comorbidity measures for use with administrative data. Med Care 1998;36:8-27
19. Public Health England, Department of Health. Annual Epidemiological Commentary: Mandatory MRSA, MSSA and E. coli bacteraemia and C. difficile infection data. 2014/15. 2015 https://www.gov.uk/government/publications. PHE publications gateway number: 2015167. [Accessed: 1st November 2015]
20. Dancer SJ, Kirkpatrick P, Corcoran DS et al. Approaching zero: temporal effects of a restrictive antibiotic policy on hospital-acquired Clostridium difficile, extended-spectrum beta-lactamase-producing coliforms and meticillin-resistant Staphylococcus aureus. Int J Antimicrob Agents 2013; 41:137-42
21. Jen MH, Saxena S, Bottle A et al. Assessment of administrative data for evaluating the shifting acquisition of Clostridium difficile infection in England. J Hosp Infect 2012;80:229-37
22. Jones AM, Kuijper EJ, Wilcox MH. Clostridium difficile: a European perspective. J Infect 2013;66:115-28
23. Office National Statistics. Deaths Involving Clostridium Difficile-England and Wales, 2006 to 2010. 2011 http://www.ons.gov.uk/ons/rel/subnationalhealth2/deaths-involving-clostridium-difficile/2006-to-2010/statisticalbulletin. html [Accessed: 1st November 2015]
24. Aldeyab MA, Kearney MP, Scott MG et al. An evaluation of the impact of antibiotic stewardship on reducing the use of high-risk antibiotics and its effect on the incidence of Clostridium difficile infection in hospital settings. J Antimicrob Chemother 2012;67:2988-96
25. Marufu O, Desai N, Aldred D et al. Analysis of interventions to reduce the incidence of Clostridium difficile infection at a London teaching hospital trust, 2003-2011. J Hosp Infect 2015;89:38-45
26. Sarma JB, Marshall B, Cleeve V et al. Effects of fluoroquinolone restriction (from 2007 to 2012) on Clostridium difficile infections: interrupted time-series analysis. J Hosp Infect 2015;91:74-80
27. McCarthy M. US aims to cut antibiotic use in new five year plan to combat antibiotic resistant bacteria. BMJ 2015;350:h1732. [Online] http://dx. doi.org/10.1136/bmj.h1732
28. The White House. National action plan for combating antibiotic-resistant bacteria. 2015 https://www.whitehouse.gov/sites/default/files/docs/national_ action_plan_for_combating_antibotic-resistant_bacteria.pdf [Accessed: 1st November 2015]
29. Centre for Disease Control and Prevention. National and State Heathcare Associated Infections Progress Report. Available at: http://www.cdc.gov/HAI/pdfs/progress-report/hai-progress-report.pdf [Accessed: 1st November 2015]
30. Lozupone CA, Stombaugh JI, Gordon JI et al. Diversity, stability and resilience of the human gut microbiota. Nature 2012;489:220-30
31. Suzuki TA, Worobey M. Geographical variation of human gut microbial composition. Biol Lett 2014;10[Online] http://dx.doi.org/10.1098/rsbl.2013.1037
32. Van Boeckel TP, Gandra S, Ashok A et al. Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data. Lancet Infect Dis 2014;14:742-50
33. Burns EM, Rigby E, Mamidanna R et al. Systematic review of discharge coding accuracy. J Public Health 2012;34:138-48
34. Khanna S, Pardi DS, Aronson SL et al. The Epidemiology of Community-Acquired Clostridium difficile Infection: A Population-Based Study. Am J Gastroenterol 2012;107:89-95
35. Chitnis AS, Holzbauer SM, Belflower RM et al. Epidemiology of Community-Associated Clostridium difficile Infection, 2009 Through 2011 JAMA Intern Med 2013;173:1359-67
36. Jarman B, Aylin P, Bottle A. Discharge destination and length of stay: differences between US and English hospitals for people aged 65 and over. BMJ 2004;328 [Online] http://dx.doi.org/10.1136/bmj.328.7440.605
37. Burnham CA, Carroll KC. Diagnosis of Clostridium difficile infection: an ongoing conundrum for clinicians and for clinical laboratories. Clin Micro Rev 2013;26:604-30
38. Gould CV, Edwards JR, Cohen J et al. Effect of nucleic acid amplification testing on population-based incidence rates of Clostridium difficile infection. Clin Infect Dis 2013;57:1304-7
39. Polage CR, Gyorke CE, Kennedy MA et al. Overdiagnosis of Clostridium difficile Infection in the Molecular Test Era. JAMA Intern Med 2015;175: 1792-801